I now have enough textbook content to compile a comprehensive, easy-to-memorise guide on Near Total Laryngectomy. Let me write the complete answer.
Near Total Laryngectomy (NTL) - A Complete, Easy-to-Memorise Guide
The One-Line Concept
NTL = Remove almost all of the larynx, but save ONE arytenoid + a sliver of cricoid to build a biological voice shunt. Patient breathes through a permanent stoma but speaks using lung air through the shunt.
Think of it as: halfway between total laryngectomy (no voice) and voice-conserving procedures (normal breathing + voice).
The "Big Picture" Spectrum
| Procedure | Voice? | Nasal Breathing? |
|---|
| Voice-conserving surgery (e.g. SCPL) | Yes | Yes |
| Near Total Laryngectomy (NTL) | Yes (lung-powered) | No (permanent stoma) |
| Total Laryngectomy | No | No |
NTL sits exactly in the middle - it sacrifices nasal respiration to save voice.
Why It Was Invented
After total laryngectomy, patients need tracheoesophageal prostheses (TEP) for voice. TEPs have long-term problems - leakage, granulation tissue, yeast infections. NTL was developed by Pearson and Tucker as a way to create a natural, biological voice shunt that avoids any prosthesis entirely.
- Cummings Otolaryngology, p. 2113
Anatomy to Remember
The key anatomical point: the larynx is a paired structure. In NTL, you exploit the fact that one side can be completely diseased while the other side (contralateral arytenoid + cord + a portion of cricoid) is used to build the shunt.
The shunt is an innervated myomucosal tube - it has:
- Muscle (so it can act as a dynamic valve/sphincter)
- Mucosa (to line the tube)
- Nerve supply (so it actively contracts to prevent aspiration)
Indications
The golden rule: advanced but LATERALISED cancer
Specifically indicated for:
- Advanced (T3/T4) hypopharyngeal cancers (pyriform sinus - the most common hypopharyngeal site) that are lateralised
- Glottic cancers unsuitable for other conservation procedures
- Suits approximately 20% of advanced, operable pyriform sinus cancers
What must be intact on the contralateral (healthy) side:
-
Contralateral arytenoid - this is the cornerstone of the shunt
-
Less than 1/3 of contralateral vocal cord involved by tumour (need enough remnant)
-
Post-cricoid mucosa must be free of tumour
-
Interarytenoid region must be uninvolved
-
Scott-Brown's Otorhinolaryngology, p. 328-329
Contraindications
Absolute Contraindications
- Interarytenoid involvement - makes preservation of the contralateral arytenoid oncologically unsafe
- Post-cricoid involvement - same reason; shunt can't be made safely
- More than 1/3 of contralateral cord involved - insufficient remnant for shunt formation
Relative Contraindication
- Prior radiotherapy (especially with oedematous tissues) - healing is compromised, shunt may fail
How the Shunt Works (The Key Concept)
BREATHING (normal):
Air → Stoma → Trachea → Lungs
(patient breathes through the neck, like total laryngectomy)
SPEAKING:
Patient covers stoma with finger
→ Air from lungs diverts UP through the shunt
→ Shunt tube vibrates → voice produced in neopharynx
→ Sphincteric muscle of shunt CLOSES after speech
→ Prevents aspiration
The shunt is dynamic - it opens for speech, closes for swallowing because it retains its nerve supply. This is the critical difference from a TEP prosthesis (which is passive).
Surgical Steps (Simplified)
What you REMOVE:
- Entire laryngeal framework on the tumour side
- Corresponding vocal cord, arytenoid, thyroid cartilage wing
- The bulk of the larynx
- Involved pharynx (partial pharyngectomy on the diseased side)
What you KEEP (the shunt components):
- Contralateral arytenoid (the hinge of the shunt valve)
- Contralateral vocal cord + mucosa (lines the shunt)
- Small portion of contralateral cricoid (the base)
- The nerve and blood supply to these remnants (so shunt stays dynamic)
What you BUILD:
- The preserved remnant is fashioned into a myomucosal tube
- This tube runs from the trachea below → neopharynx above
- The tube is too narrow to breathe through (inadequate for airway), but large enough to shunt air for voice
Permanent tracheostomy:
- Always created, just like in total laryngectomy
- Patient will breathe through this stoma for life
Functional Outcomes
Voice
- Almost all patients achieve intelligible, lung-powered speech
- Published success rates: 74% to 100% across series
- Most common complication of voice: NTL shunt stenosis
- Managed with dilatation using gum elastic bougies
- No prosthesis required - completely biological
Swallowing
-
The sphincteric action of the innervated shunt protects the airway
-
Aspiration is prevented because the remnant muscle actively contracts
-
Scott-Brown's Otorhinolaryngology, p. 329
Oncological Outcomes
-
In properly selected cases, locoregional control rates are comparable to total laryngectomy
-
Local recurrence rate: < 7% in predominantly T3/T4 series
-
Median 5-year survival: ~57%
-
These figures are reassuring - NTL is not oncologically inferior to total laryngectomy when patient selection is correct
-
Scott-Brown's Otorhinolaryngology, p. 330
Neck Dissection (Always Done)
Because these are advanced (T3/T4) cancers:
- With manifest neck nodes (N1-N3): Bilateral neck dissection levels II-V
- Advanced primary, no clinically apparent nodes: Bilateral levels II-IV neck dissection
Adjuvant Therapy
Most patients require postoperative radiotherapy or chemoradiotherapy if:
- T3/T4 primary
- Close or positive cut margins
- Perineural invasion (PNI)
- Lymphovascular emboli (LVE)
- Cartilage invasion
- Multiple nodes / extracapsular spread (ECS)
Concurrent chemotherapy + RT is indicated for positive margins and extracapsular spread specifically.
Complications
| Complication | Notes |
|---|
| Shunt stenosis | Most common voice problem; treat with dilatation |
| Salivary fistula | More common in post-irradiated patients (~50%) |
| Aspiration | Rare if shunt is functioning properly (sphincter protects) |
| Stomal complications | As with total laryngectomy |
Memory Anchors
"NTLP = Preserve ONE side, shunt for voice, stoma for air"
| Mnemonic | Meaning |
|---|
| Not nasal breathing | Permanent stoma - no nasal breathing |
| Tube = the shunt | Myomucosal tube is the biological shunt |
| Lung-powered voice | Lung air through shunt = voice (no prosthesis) |
| Pearson & Tucker | The surgeons who pioneered this technique |
Shunt contraindications = "Inter-Post-One-third":
- Interarytenoid involvement
- Post-cricoid involvement
- More than one-third of contralateral cord involved
Quick Comparison with Related Procedures
| Feature | Supracricoid PL (SCPL) | Near Total Laryngectomy (NTL) | Total Laryngectomy |
|---|
| Tracheostomy | Temporary | Permanent | Permanent |
| Nasal breathing restored | Yes (eventually) | No | No |
| Voice mechanism | Cricohyoidopexy (biological) | Myomucosal shunt | TEP prosthesis or esophageal speech |
| Organ-sparing | Yes | No | No |
| Indication | T2-T3 glottic/supraglottic | Advanced lateralised | Any resectable larynx Ca |
Sources:
- Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol. 1, pp. 328-330 (NTLP section)
- Cummings Otolaryngology Head and Neck Surgery, pp. 1994, 2113 (NTL in glottic SCC and voice rehabilitation)